Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Mast cell-induced lung injury in mice infected with H5N1 influenza virus.

Hu Y, Jin Y, Han D, Zhang G, Cao S, Xie J, Xue J, Li Y, Meng D, Fan X, Sun LQ, Wang M.

J Virol. 2012 Mar;86(6):3347-56. doi: 10.1128/JVI.06053-11. Epub 2012 Jan 11.

2.

Molecular signatures associated with Mx1-mediated resistance to highly pathogenic influenza virus infection: mechanisms of survival.

Cilloniz C, Pantin-Jackwood MJ, Ni C, Carter VS, Korth MJ, Swayne DE, Tumpey TM, Katze MG.

J Virol. 2012 Mar;86(5):2437-46. doi: 10.1128/JVI.06156-11. Epub 2011 Dec 21.

3.

Synergistic adaptive mutations in the hemagglutinin and polymerase acidic protein lead to increased virulence of pandemic 2009 H1N1 influenza A virus in mice.

Seyer R, Hrincius ER, Ritzel D, Abt M, Mellmann A, Marjuki H, Kühn J, Wolff T, Ludwig S, Ehrhardt C.

J Infect Dis. 2012 Jan 15;205(2):262-71. doi: 10.1093/infdis/jir716. Epub 2011 Nov 18.

PMID:
22102733
4.

Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses.

Kash JC, Walters KA, Davis AS, Sandouk A, Schwartzman LM, Jagger BW, Chertow DS, Li Q, Kuestner RE, Ozinsky A, Taubenberger JK.

MBio. 2011 Sep 20;2(5). pii: e00172-11. doi: 10.1128/mBio.00172-11. Print 2011.

5.

2009 pandemic H1N1 influenza virus causes disease and upregulation of genes related to inflammatory and immune responses, cell death, and lipid metabolism in pigs.

Ma W, Belisle SE, Mosier D, Li X, Stigger-Rosser E, Liu Q, Qiao C, Elder J, Webby R, Katze MG, Richt JA.

J Virol. 2011 Nov;85(22):11626-37. doi: 10.1128/JVI.05705-11. Epub 2011 Sep 7.

6.
7.

Mutations in PA, NP, and HA of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice.

Sakabe S, Ozawa M, Takano R, Iwastuki-Horimoto K, Kawaoka Y.

Virus Res. 2011 Jun;158(1-2):124-9. doi: 10.1016/j.virusres.2011.03.022. Epub 2011 Mar 31.

8.

The predominant expression of hepatocyte nuclear factor 4α (HNF4α) in thyroid transcription factor-1 (TTF-1)-negative pulmonary adenocarcinoma.

Kunii R, Jiang S, Hasegawa G, Yamamoto T, Umezu H, Watanabe T, Tsuchida M, Hashimoto T, Hamakubo T, Kodama T, Sasai K, Naito M.

Histopathology. 2011 Feb;58(3):467-76. doi: 10.1111/j.1365-2559.2011.03764.x. Epub 2011 Feb 23.

PMID:
21348892
9.

H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response.

Viemann D, Schmolke M, Lueken A, Boergeling Y, Friesenhagen J, Wittkowski H, Ludwig S, Roth J.

J Immunol. 2011 Jan 1;186(1):164-73. doi: 10.4049/jimmunol.0904170. Epub 2010 Nov 24.

10.

Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques.

Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, Brining D, Gardner D, Proll SC, Marzi A, Tsuda Y, Lacasse RA, Kercher L, York A, Korth MJ, Long D, Rosenke R, Shupert WL, Aranda CA, Mattoon JS, Kobasa D, Kobinger G, Li Y, Taubenberger JK, Richt JA, Parnell M, Ebihara H, Kawaoka Y, Katze MG, Feldmann H.

J Virol. 2011 Feb;85(3):1214-23. doi: 10.1128/JVI.01848-10. Epub 2010 Nov 17.

11.

Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype?

Ye J, Sorrell EM, Cai Y, Shao H, Xu K, Pena L, Hickman D, Song H, Angel M, Medina RA, Manicassamy B, Garcia-Sastre A, Perez DR.

PLoS Pathog. 2010 Oct 14;6(10):e1001145. doi: 10.1371/journal.ppat.1001145.

12.

PB2 residue 158 is a pathogenic determinant of pandemic H1N1 and H5 influenza a viruses in mice.

Zhou B, Li Y, Halpin R, Hine E, Spiro DJ, Wentworth DE.

J Virol. 2011 Jan;85(1):357-65. doi: 10.1128/JVI.01694-10. Epub 2010 Oct 20.

13.

Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism.

Theken KN, Deng Y, Kannon MA, Miller TM, Poloyac SM, Lee CR.

Drug Metab Dispos. 2011 Jan;39(1):22-9. doi: 10.1124/dmd.110.035287. Epub 2010 Oct 14.

14.

Genomic profiling of tumor necrosis factor alpha (TNF-alpha) receptor and interleukin-1 receptor knockout mice reveals a link between TNF-alpha signaling and increased severity of 1918 pandemic influenza virus infection.

Belisle SE, Tisoncik JR, Korth MJ, Carter VS, Proll SC, Swayne DE, Pantin-Jackwood M, Tumpey TM, Katze MG.

J Virol. 2010 Dec;84(24):12576-88. doi: 10.1128/JVI.01310-10. Epub 2010 Oct 6.

15.

HNF4α--role in drug metabolism and potential drug target?

Hwang-Verslues WW, Sladek FM.

Curr Opin Pharmacol. 2010 Dec;10(6):698-705. doi: 10.1016/j.coph.2010.08.010. Review.

16.

Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice.

Moseley CE, Webster RG, Aldridge JR.

Influenza Other Respir Viruses. 2010 Sep;4(5):307-11. doi: 10.1111/j.1750-2659.2010.00155.x.

17.

Host response to influenza virus: protection versus immunopathology.

Peiris JS, Hui KP, Yen HL.

Curr Opin Immunol. 2010 Aug;22(4):475-81. doi: 10.1016/j.coi.2010.06.003. Epub 2010 Jun 30. Review.

18.

Adaptation of pandemic H1N1 influenza viruses in mice.

Ilyushina NA, Khalenkov AM, Seiler JP, Forrest HL, Bovin NV, Marjuki H, Barman S, Webster RG, Webby RJ.

J Virol. 2010 Sep;84(17):8607-16. doi: 10.1128/JVI.00159-10. Epub 2010 Jun 30.

19.

Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study.

Schouten M, Sluijs KF, Gerlitz B, Grinnell BW, Roelofs JJ, Levi MM, van 't Veer C, van der Poll T.

Crit Care. 2010;14(2):R65. doi: 10.1186/cc8964. Epub 2010 Apr 14.

20.

Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice.

Belser JA, Wadford DA, Pappas C, Gustin KM, Maines TR, Pearce MB, Zeng H, Swayne DE, Pantin-Jackwood M, Katz JM, Tumpey TM.

J Virol. 2010 May;84(9):4194-203. doi: 10.1128/JVI.02742-09. Epub 2010 Feb 24.

Supplemental Content

Support Center